Beaufort CRO
Yasmeen Taswell is an accomplished professional with extensive experience in clinical quality oversight and business development. Currently serving as the Director of Clinical Monitoring Oversight at Beaufort CRO since January 2013, Yasmeen plays a vital role in the global Independent Clinical Quality Evaluation team, providing oversight for clinical research studies and managing various quality oversight projects. Prior to this position, Yasmeen held several roles at Mary Kay Inc. from April 2011 to December 2021, including Manager of Marketing and Business Development and Client Resource Manager, in addition to earlier experience as a Team Leader at Silver Diner. Yasmeen holds a Bachelor of Science degree in Biology from Christopher Newport University, earned in 2008.
This person is not in any offices
Beaufort CRO
Beaufort is a global CRO built around one purpose — helping life science companies improve and save lives through the rapid development and commercialization of innovative products. Our shared interest and commitment to your success drives our entire organization to deliver best-in-class clinical trial services, regulatory strategy and planning, data and business analytics, data management and statistics, and quality services. We are: ◈ MedTech Focused - Industry-leading expertise to streamline your clinical development. ◈ IVD Specialists - Two decades of extensive diagnostic experience. ◈ Results Oriented - Guided by efficient and adaptive clinical trial management. ◈ Partnership Driven - 94% of clients rate Beaufort higher than other CROs Our experience includes: ◈ 500+ Regulatory Submissions including 510(k)s, PMAs, IDEs and CE-Marks ◈ 4,000+ Clinical Study Sites Around the Globe ◈ 1,000+ Clinical Trials Across a Wide Variety of Indications and Testing Platforms ◈ 2,600+ Clinical Professionals in Over 50 Countries See how Beaufort CRO can accelerate your medical innovation -- and put our experience to work for you.